PEPCID Drug Patent Profile
✉ Email this page to a colleague
When do Pepcid patents expire, and what generic alternatives are available?
Pepcid is a drug marketed by Salix Pharms, Merck, Bausch, J And J Consumer Inc, and Merck Sharp Dohme. and is included in nine NDAs.
The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
Summary for PEPCID
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Clinical Trials: | 35 |
Patent Applications: | 6,700 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PEPCID |
What excipients (inactive ingredients) are in PEPCID? | PEPCID excipients list |
DailyMed Link: | PEPCID at DailyMed |
Recent Clinical Trials for PEPCID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University Comprehensive Cancer Center | Phase 2/Phase 3 |
United States Department of Defense | Phase 2 |
Leidos Life Sciences | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for PEPCID
US Patents and Regulatory Information for PEPCID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Salix Pharms | PEPCID | famotidine | FOR SUSPENSION;ORAL | 019527-001 | Feb 2, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
J And J Consumer Inc | PEPCID AC | famotidine | TABLET;ORAL | 020325-001 | Apr 28, 1995 | OTC | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bausch | PEPCID | famotidine | TABLET;ORAL | 019462-002 | Oct 15, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck Sharp Dohme | PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER | famotidine | INJECTABLE;INJECTION | 020249-001 | Feb 18, 1994 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEPCID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | PEPCID | famotidine | TABLET;ORAL | 019462-001 | Oct 15, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch | PEPCID | famotidine | TABLET;ORAL | 019462-002 | Oct 15, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
Salix Pharms | PEPCID | famotidine | FOR SUSPENSION;ORAL | 019527-001 | Feb 2, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | PEPCID | famotidine | INJECTABLE;INJECTION | 019510-001 | Nov 4, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PEPCID
See the table below for patents covering PEPCID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 70890 | ⤷ Try a Trial | |
Spain | 487381 | ⤷ Try a Trial | |
Germany | 3008056 | ⤷ Try a Trial | |
Netherlands | 930038 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |